Statements (492)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
gptkb:Company |
| gptkbp:acquired |
gptkb:Crop_Science
gptkb:Covestro_AG gptkb:Monsanto gptkb:Agra_Quest gptkb:Monsanto_seed_business gptkb:animal_health_business_of_Merck_KGa_A gptkb:crop_protection_business_of_Du_Pont Crop Science Division Schering AG pharmaceutical business Adempas rights Crop Science Division of Monsanto Merck's consumer health business Merck's rights to Verquvo animal health business of Elanco Animal Health animal health portfolio rights in 2020 rights to Adempas rights to Fintepla rights to Nubeqa rights to Stivarga rights to Verquvo rights to Vitrakvi consumer health business of Merck KGa A |
| gptkbp:acquired_assets_worth |
4 billion euros
|
| gptkbp:acquired_by |
gptkb:Blue_Rock_Therapeutics
gptkb:Xarelto gptkb:Athenex gptkb:pharmaceuticals gptkb:Alka-Seltzer gptkb:Covestro gptkb:Claritin gptkb:Merck_KGa_A gptkb:Dr._Scholl's gptkb:2014 gptkb:2021 gptkb:Ceres,_Inc. gptkb:Elanco_Animal_Health gptkb:Essity gptkb:Monsanto gptkb:Coppertone gptkb:Eylea gptkb:Nant_Kwest gptkb:Agra_Quest gptkb:Bepanthen gptkb:Canesten gptkb:Kogenate gptkb:One_A_Day Algeta Mediq St. Louis-based Monsanto Asklepios Bio Pharmaceuticals Conceptus Medi Gene KGa A |
| gptkbp:acquired_vitrakvi_to_enhance |
oncology portfolio
|
| gptkbp:acquisition |
gptkb:Blue_Rock_Therapeutics
gptkb:Vividion_Therapeutics gptkb:Athenex gptkb:Covestro gptkb:Nant_Kwest,_Inc. gptkb:Asklepios_Bio_Pharmaceutical gptkb:Kymab gptkb:Dihon_Pharmaceutical_Group gptkb:Kraton_Corporation gptkb:Ceres,_Inc. gptkb:Covestro_AG gptkb:Ginkgo_Bioworks gptkb:Schering_AG gptkb:Monsanto gptkb:expansion gptkb:Agra_Quest Algeta Increased market share Merger 7.6 billion USD 63 billion USD increased market share diversification increased revenue potential cost savings diversification of product lines approximately $4 billion $19 billion global presence improved customer service increased innovation enhanced brand reputation synergies growth opportunities improved product offerings diversified business operations improved marketing strategies increased shareholder value strengthened partnerships growth through acquisition $63 billion enhanced sustainability initiatives enhanced brand recognition enhanced global reach increased focus on innovation improved financial performance improved health outcomes. enhanced research capabilities strengthened market position improved risk management Expand product portfolio increased focus on preventive care improved supply chain management enhanced customer base expanded geographic reach greater investment in technology synergies in operations increased collaboration opportunities expanded market presence improved regulatory compliance enhanced corporate social responsibility improved supply chain efficiency St. Louis-based Monsanto enhanced marketing capabilities increased innovation potential synergies with existing products expansion in agriculture 19 billion euros broadened product pipeline broadened therapeutic areas enhanced clinical trial capabilities enhanced competitive advantage enhanced partnerships with academic institutions enhanced product development expanded animal health portfolio expanded product portfolio expansion in consumer health greater access to emerging markets greater emphasis on digital health solutions greater focus on patient needs greater investment in health technology improved competitive position improved patient access to therapies improved product development timelines increased access to new markets increased collaboration with healthcare providers increased focus on personalized medicine increased investment in animal health increased product portfolio increased sales force strengthened R& D capabilities strengthened global presence strengthened intellectual property portfolio strengthened position in cardiology strengthened position in oncology strengthened position in women's health strengthened regulatory compliance synergies in agriculture synergies in crop protection enhanced product portfolio to strengthen market position Asklepios Bio Pharmaceuticals Conceptus |
| gptkbp:acquisition_year |
gptkb:2002
gptkb:2006 gptkb:2016 gptkb:2018 gptkb:2020 June 7, 2018 |
| gptkbp:advocates_for |
responsible sourcing
|
| gptkbp:aims_to |
unmet medical needs
carbon neutrality by 2030 zero waste to landfill |
| gptkbp:aims_to_improve |
gptkb:transparency_in_operations
carbon footprint food security greenhouse gas emissions local communities patient outcomes renewable energy usage employee well-being supply chain transparency sustainable consumption effective treatments stakeholder engagement in sustainability plastic usage water usage in production |
| gptkbp:capital |
approximately $60 billion
approximately 50 billion euros |
| gptkbp:categories |
gptkb:pharmaceuticals
crop science consumer health |
| gptkbp:ceo |
gptkb:Werner_Baumann
Marijn Dekkers (former) |
| gptkbp:challenges |
regulatory scrutiny
|
| gptkbp:challenges_post-acquisition |
regulatory scrutiny
|
| gptkbp:collaborates_with |
gptkb:healthcare_professionals
governments on sustainability policies other organizations for sustainability |
| gptkbp:conducts_research_on |
Dr. Joerg Moeller
|
| gptkbp:controversy |
Legal issues
|
| gptkbp:customer_base |
gptkb:farmers
|
| gptkbp:dedicated_to |
advancing science
|
| gptkbp:develops |
sustainable products
sustainable packaging solutions sustainable farming techniques environmentally friendly products |
| gptkbp:divisions |
gptkb:pharmaceuticals
gptkb:Crop_Science Pharmaceuticals Animal Health Consumer Health crop science consumer health |
| gptkbp:employees |
approximately 100,000
99,000 approximately 100,000 (2020) 99,820 (2020) |
| gptkbp:employs |
over 100,000 people
|
| gptkbp:encourages |
sustainable practices among consumers
|
| gptkbp:engages_in |
research and development
sustainability reporting stakeholders on sustainability sustainability partnerships |
| gptkbp:enhances |
health and nutrition
|
| gptkbp:environmental_initiatives |
sustainable farming practices
|
| gptkbp:established |
1863
|
| gptkbp:exhibition_focus |
innovation
|
| gptkbp:financial_performance |
strong
strong revenue growth |
| gptkbp:focus |
Pharmaceuticals, Consumer Health, Crop Science, Animal Health
|
| gptkbp:focuses_on |
agriculture
healthcare research and development sustainability water conservation healthcare and agriculture healthcare sustainability |
| gptkbp:founded |
1863
|
| gptkbp:founded_in |
1863
|
| gptkbp:founder |
gptkb:Friedrich_Bayer
|
| gptkbp:future_plans |
expand product portfolio
expand biotechnology offerings |
| gptkbp:global_presence |
gptkb:Yes
over 100 countries over 80 countries operates in over 100 countries pharmaceutical markets |
| gptkbp:has |
global presence
|
| gptkbp:has_a_focus_on |
gptkb:sustainable_development_goals
patient safety sustainability digital transformation collaborative research health equity access to medicines patient-centric solutions |
| gptkbp:has_a_presence_in |
over 100 countries
emerging markets |
| gptkbp:has_diversity_initiatives |
crop protection products
various therapeutic areas into biotechnology |
| gptkbp:has_goal |
2030 Sustainability Goals
|
| gptkbp:has_history |
mergers and acquisitions
pharmaceutical innovation |
| gptkbp:has_mission |
improve health and quality of life
|
| gptkbp:has_partnerships_with |
research institutions
various healthcare organizations various research institutions |
| gptkbp:has_received |
numerous awards
|
| gptkbp:has_research_center |
gptkb:Germany
|
| gptkbp:head_of_agriculture |
gptkb:Bob_Reiter
|
| gptkbp:head_of_animal_health |
Monique R. Henneman
|
| gptkbp:head_of_consumer_health |
gptkb:Dawn_Zier
|
| gptkbp:head_of_crop_science |
gptkb:Liam_Condon
|
| gptkbp:headquartered_in |
gptkb:Leverkusen,_Germany
gptkb:Leverkusen |
| gptkbp:headquarters |
gptkb:Germany
gptkb:Leverkusen,_Germany |
| https://www.w3.org/2000/01/rdf-schema#label |
Bayer
|
| gptkbp:implements |
sustainable supply chain practices
|
| gptkbp:industry |
gptkb:pharmaceuticals
Pharmaceuticals agriculture |
| gptkbp:innovation |
gptkb:Yes
key focus area focus on biotechnology |
| gptkbp:investment |
gptkb:biotechnology
agricultural innovation sustainable technology community development projects biotechnology innovations innovation for sustainability research for sustainable solutions |
| gptkbp:investment_strategy |
varied
|
| gptkbp:involved_in |
pharmaceutical research
|
| gptkbp:is_a_global_leader_in |
gptkb:pharmaceuticals
healthcare solutions |
| gptkbp:is_a_member_of |
gptkb:DAX_index
various industry associations |
| gptkbp:is_aligned_with |
gptkb:UN_Sustainable_Development_Goals
|
| gptkbp:is_committed_to |
gptkb:healthcare_access
community engagement diversity and inclusion innovation patient safety sustainability sustainable agriculture ethical business practices environmental stewardship |
| gptkbp:is_displayed_in |
gptkb:Frankfurt_Stock_Exchange
the Frankfurt Stock Exchange |
| gptkbp:is_focused_on |
innovation in medicine
|
| gptkbp:is_involved_in |
gptkb:biotechnology
research and development animal health clinical trials public health initiatives global health initiatives global health challenges healthcare access initiatives vaccine development. |
| gptkbp:is_known_for |
aspirin
|
| gptkbp:is_recognized_for |
gptkb:scientific_research
corporate social responsibility innovation in drug development its contributions to healthcare |
| gptkbp:key_people |
gptkb:Werner_Baumann
|
| gptkbp:known_for |
gptkb:pharmaceuticals
crop science aspirin |
| gptkbp:leadership |
pharmaceutical innovation
the pharmaceutical industry |
| gptkbp:legal_issue |
Lawsuits over glyphosate
|
| gptkbp:market |
global
|
| gptkbp:market_cap |
approximately €50 billion (2020)
50 billion EUR (2018) |
| gptkbp:market_leader |
gptkb:Yes
|
| gptkbp:market_position |
leading
|
| gptkbp:marketing_strategy |
gptkb:Software_Solutions
sustainable agriculture |
| gptkbp:measures_progress_in |
sustainability initiatives
|
| gptkbp:number_of_employees |
approximately 100,000
|
| gptkbp:offers |
healthcare products
|
| gptkbp:operates |
in more than 80 countries
|
| gptkbp:operates_in |
gptkb:pharmaceuticals
agriculture healthcare animal health over 100 countries agricultural science over 80 countries crop science consumer health agricultural sciences |
| gptkbp:partnership |
gptkb:Medi_Wound_Ltd.
gptkb:Blue_Rock_Therapeutics gptkb:Celgene_Corporation gptkb:Evotec_AG gptkb:Genentech gptkb:Illumina,_Inc. gptkb:Bill_&_Melinda_Gates_Foundation gptkb:Ceres_Global_Ag_Corp. gptkb:Johnson_&_Johnson gptkb:Bayer_Crop_Science gptkb:Takeda_Pharmaceutical_Company gptkb:Bayer_Health_Care gptkb:Astra_Zeneca gptkb:Sanofi gptkb:Boehringer_Ingelheim gptkb:Bristol-Myers_Squibb gptkb:World_Wildlife_Fund gptkb:Pfizer gptkb:Regeneron_Pharmaceuticals gptkb:Merck_&_Co. gptkb:Roche gptkb:Amgen gptkb:CRISPR_Therapeutics gptkb:Eli_Lilly_and_Company gptkb:Ginkgo_Bioworks gptkb:Vertex_Pharmaceuticals gptkb:Sierra_Oncology gptkb:Abb_Vie gptkb:Glaxo_Smith_Kline gptkb:UNICEF gptkb:Cure_Vac gptkb:Novartis gptkb:Evotec various health initiatives |
| gptkbp:partnerships |
various universities
various agricultural companies collaborates with universities |
| gptkbp:philanthropy |
gptkb:Bayer_Fund
gptkb:Bayer_Science_&_Education_Foundation gptkb:Bayer_Cares_Foundation gptkb:Bayer_Crop_Science_Foundation gptkb:Bayer_Health_Care_Foundation |
| gptkbp:portfolio_company |
oncology drugs
healthcare products |
| gptkbp:produces |
pharmaceuticals for humans
|
| gptkbp:product |
gptkb:Xarelto
gptkb:pharmaceuticals gptkb:Alka-Seltzer gptkb:Claritin gptkb:Cipro |
| gptkbp:product_line |
gptkb:pharmaceuticals
crop protection consumer health products crop science products |
| gptkbp:products |
gptkb:Xarelto
gptkb:pharmaceuticals gptkb:Advil gptkb:Claritin gptkb:Eylea Pharmaceuticals herbicides aspirin Crop protection products crop science products |
| gptkbp:promotes |
biodiversity
sustainable land use practices circular economy principles employee engagement in sustainability |
| gptkbp:regulatory_compliance |
received from multiple countries
required for acquisition |
| gptkbp:reported_revenue_of |
€41.4 billion in 2020
|
| gptkbp:reports_to |
sustainability performance
|
| gptkbp:research_and_development |
gptkb:biotechnology
healthcare significant investment €5 billion (2020) €5 billion annually |
| gptkbp:research_focus |
Life sciences
oncology radiology women's health agricultural sciences cardiovascular |
| gptkbp:revenue |
approximately €43 billion
€43.5 billion (2020) approximately €43 billion (2020) approximately 43 billion euros 46.2 billion EUR (2016) |
| gptkbp:slogan |
Science for a better life
|
| gptkbp:social_responsibility |
active
focuses on health and nutrition |
| gptkbp:stock_exchange |
gptkb:Frankfurt_Stock_Exchange
FWB |
| gptkbp:stock_symbol |
gptkb:BAYN
|
| gptkbp:subsidiaries |
gptkb:Bayer_Crop_Science
gptkb:Bayer_Health_Care gptkb:Crop_Science |
| gptkbp:subsidiary |
gptkb:Bayer_Crop_Science
gptkb:Bayer_Health_Care gptkb:Crop_Science gptkb:Monsanto gptkb:Bayer_Material_Science over 80 countries |
| gptkbp:supply_chain |
global supply chain
|
| gptkbp:supports |
climate action
education on sustainability sustainable development initiatives climate resilience initiatives |
| gptkbp:sustainability |
focus on health and nutrition
|
| gptkbp:sustainability_efforts |
reduce environmental impact
improve biodiversity carbon neutrality by 2030 reduce plastic waste |
| gptkbp:sustainability_initiatives |
gptkb:Yes
gptkb:Bayer_Forward_Farming gptkb:Bayer_Global_Sustainability_Council various programs promotes sustainable agriculture Bayer Bee Care Program Bayer Climate Program Bayer Health for All Program |
| gptkbp:targets |
waste reduction
|
| gptkbp:traded_on |
gptkb:New_York_Stock_Exchange
gptkb:Frankfurt_Stock_Exchange |
| gptkbp:trademark |
gptkb:Bayer_Aspirin
gptkb:Bayer_Pharmaceuticals gptkb:Bayer_Advanced gptkb:Bayer_Cross gptkb:Bayer_Environmental_Science |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.bayer.com
|
| gptkbp:bfsParent |
gptkb:Merck_KGa_A
gptkb:West_Germany gptkb:Regeneron_Pharmaceuticals gptkb:Merck_&_Co. gptkb:Amgen gptkb:Ginkgo_Bioworks gptkb:Regeneron gptkb:2011_FIFA_Women's_World_Cup |
| gptkbp:bfsLayer |
4
|